acitretin has been researched along with Hypomelanosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assaf, M; Esmat, S; Hilal, RF; Ramadan, S; Saleh, NA; Zeid, OA | 1 |
| Abdolkarimi, B; Aslani, FS; Karimi, M; Mokhtari, M; Sepaskhah, M | 1 |
| Farley-Loftus, R; Latkowski, JA; Mandal, R | 1 |
| Aydin, NE; Karaca, S; Ozcan, A; Senol, M | 1 |
4 other study(ies) available for acitretin and Hypomelanosis
| Article | Year |
|---|---|
Combination of acitretin and narrowband UV-B for the treatment of vitiligo: A new treatment modality with an impact on tissue E-cadherin expression.
Topics: Acitretin; Cadherins; Combined Modality Therapy; Humans; Hypopigmentation; Treatment Outcome; Ultraviolet Therapy; Vitiligo | 2023 |
Hypo-pigmented mycosis fungoides is a rare malignancy in pediatrics.
Topics: Acitretin; Child; Fluocinolone Acetonide; Glucocorticoids; Humans; Hypopigmentation; Keratolytic Agents; Male; Mycosis Fungoides; Skin Neoplasms | 2018 |
Poikilodermatous mycosis fungoides.
Topics: Acitretin; Antineoplastic Agents; Bexarotene; Female; Humans; Hydroxamic Acids; Hypopigmentation; Immunophenotyping; Interferon-alpha; Middle Aged; Mycosis Fungoides; Skin Neoplasms; Tetrahydronaphthalenes; Treatment Outcome; Ultraviolet Therapy; Vorinostat | 2010 |
Amyloidosis cutis dyschromica: a case treated with acitretin.
Topics: Acitretin; Adult; Amyloidosis; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Hypopigmentation; Immunohistochemistry; Male; Severity of Illness Index; Skin Diseases; Treatment Outcome | 2005 |